Clinical Trial Update: Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety and immune response of the WN/DEN4Δ30 West Nile virus vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Fever

Drugs mentioned

• WN/DEN4Δ30 West Nile virus vaccine (WN/DEN4Δ30 West Nile virus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: West Nile Fever | Phase 1 | Status: COMPLETED